AlterDiag is a Developer of rapid diagnostic tests using single-domain antibodies.
AlterDiag has raised $2.1M in total funding. The most recent round was Seed. The last funding was announced in January 2025.
AlterDiag's investors include Forepont Capital Partners.
AlterDiag is headquartered in Clermont-ferrand, France.
AlterDiag is a Developer of rapid diagnostic tests using single-domain antibodies.
AlterDiag is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AlterDiag — Funding & Investors." VCBacked, January 29, 2025, https://www.vcbacked.co/company/alterdiag. Accessed August 2, 2026.
VCBacked. (2025). AlterDiag — Funding & Investors. Retrieved August 2, 2026, from https://www.vcbacked.co/company/alterdiag
{{cite web |title=AlterDiag — Funding & Investors |url=https://www.vcbacked.co/company/alterdiag |website=VCBacked |access-date=August 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated